Latent Cytomegalovirus Infection and Blood Transfusion

  1. GARY L. KANTOR, M.D.; and
  2. B. LAMAR JOHNSON, JR., M.D.
  1. Nephrology Section, Wadsworth General Hospital; and the Department of Medicine, UCLA School of Medicine;
    Los Angeles, Calif.

    Excerpt

    Renewed interest in the cytomegalovirus has grown from the recognition that infection with this virus may produce disease in adult patients. Disseminated infection with cytomegalovirus is an increasingly frequent complication in patients with underlying immunologic defects, whether inherited, acquired, or induced by immunosuppressive therapy (1). Fifty to 75% of renal allograft recipients ultimately develop evidence of the infection, and similar involvement occurs in patients with leukemia or lymphoproliferative disorders, particularly after cytotoxic therapy (1, 2). The clinical manifestations are protean although their significance has often been obscured by other pathogenic organisms or manifestations of the underlying disorder (3). Nevertheless, disseminated

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement